Reproducibility of visual acuity measurements in patients with retinitis pigmentosa

Retina

Volumn 17, Issue 1, 1997, Pages 33-37

  Grover, Sandeep ^a   Fishman, Gerald A ^a,b   Gilbert, Leonardo D ^a   Anderson, Robert J ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b University of Illinois Chicago   (United States)

Author keywords

reproducibility; retinitis pigmentosa; variability; visual acuity

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; HUMAN; OBSERVER VARIATION; REPRODUCIBILITY; RETINITIS PIGMENTOSA; STATISTICAL ANALYSIS; VISUAL ACUITY;

EID: 0031041935     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-199701000-00007     Document Type: Article

References (20)

1. Reeves BC, Hill AR, Aspinall PA. The clinical significance of change. Ophthalmic Physiol Opt 1987;8:441-446.
2. Klein R, Klein BEK, Moss SE, DeMets D. Interobserver variation in refraction and visual acuity measurement using a standardized protocol. Ophthalmology 1983;90:1357-1359.
3. Lovie-Kitchin JE. Validity and reliability of visual acuity measurements. Ophthalmic Physiol Opt 1988;8:363-370.
4. Elliot DB, Sheridan M. The use of accurate visual acuity measurements in clinical anti-cataract formulation trials. Ophthalmic Physiol Opt 1988;8:397-401.
5. Ichikawa H, Imaizumi K, Tazawa Y, et al. Effect of triopronin on senile cataracts. Ophthalmologica 1980;180:293-298.
6. Libutti G, Pannarale L. L'impiego della Bendalina nella terapie cataratta senile: Valutazione clinica dei risultati: Henuti dopo un anno di terapia. Boll Ocul 1985;64:645-657.
7. Sanders DR, DeGregorio M, Pioggia M. Bendazac lysine (Bendalina) as an anti-cataract agent: A review of basic clinical data. Proceedings of the XXV International Congress of Ophthalmology. Amsterdam, the Netherlands: Kruger, May 4-10, 1986, Rome, Italy.
8. Gibson RA, Sanderson HF. Observer variation in ophthalmology. Br J Ophthalmol 1980;64:457-460.
9. Berson EL, Sandberg MA, Rosner B, et al. Natural course of retinitis pigmentosa over a three-year interval. Am J Ophthalmol 1985;99:240-251.
10. Ferris FL, Kassoff A, Bresnick GH, Bailey I. New visual acuity charts for clinical research. Am J Ophthalmol 1982; 94:91-96.
11. Fishman GA. Retinitis pigmentosa: Genetic percentages. Arch Ophthalmol 1978;96:822-826.
12. Early Treatment Diabetic Retinopathy Study. In: Manual of Operations. Baltimore, MD: ETDRS Coordinating Center, University of Maryland School of Medicine, Department of Epidemiology and Preventive Medicine, 1980; ch. 12:1-15.
13. Diggle PJ, Liang KY, Zeger SL. Analysis of Longitudinal Data. New York, NY: Oxford University Press, 1994:55-68.
14. The MIXED procedure. In: SAS/STAT Software: Changes and Enhancements, Release 6.07: Technical report P-229. Cary, NC: SAS Institute Inc, 1992:620.
15. Vardeman SB. What about other intervals? Am Stat 1992;46:193-197.
16. Arditi A, Cagenello R. On the statistical reliability of letter-chart visual acuity measurements. Inv Ophthalmol Vis Sci 1993;34:120-129.
17. Flach AJ, Jampol LM, Weinberg D, et al. Improvement in visual acuity in chronic aphakic and pseudophakic cystoid macular edema after treatment with topical 0.5% ketorolac tromethamine. Am J Ophthalmol 1991;112:514-519.
18. Fishman GA, Gilbert LD, Anderson RJ, et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 1994;101:687-693.
19. Nelson ME, Orton HP. Counteracting the effects of mydriatics: Does it benefit the patient? Arch Ophthalmol 1987; 105:486-489.
20. Montgomery DMI, Macewan CJ. Pupil dilatation with tropicamide: The effects on acuity, accomodation and refraction. Eye 1989;3:845-848.